Achilles Therapeutics plc
Achilles Therapeutics Holdings Limited
Achilles Therapeutics UK Limited
(“The Companies”)

Ian Harvey Dean and Robert Scott Fishman (“the Liquidators”) were appointed Joint Liquidators of the Companies further to resolutions of the respective member of the Companies dated 20 March 2025.

All licensed Insolvency Practitioners of Teneo Financial Advisory Limited (“Teneo”) are licensed in the UK to act as Insolvency Practitioners by the Institute of Chartered Accountants in England and Wales.

For the purpose of section 231 of the Insolvency Act 1986 (“the Act”), the Liquidators confirm that they are authorised to carry out all functions, duties and powers by either of them jointly and severally.

The Liquidations are Members Voluntary (Solvent) Liquidations pursuant to the Act, all creditors will be paid in full together with any statutory interest. Creditors should contact the liquidators by emailing queries@achillestx.com and requesting a proof of debt form or via post to C/O Teneo Financial Advisory Limited, The Colmore Building 20 Colmore Circus Queensway, Birmingham, B4 6AT.

Shareholders will be notified when the liquidators intend to make a distribution from the liquidation estate of Achilles Therapeutics plc. Any investor queries should be directed via email to queries@achillestx.com or via post to the address shown above.